Sulphadoxine + Pyrimethamine
Generic Details
Generic Name
Sulphadoxine-pyrimethamine
Other Names
- SP
- Sulfadoxine-pyrimethamine
- Fansidar
Drug Class
- Antimalarial
Chemical Formula
C12H14N4O4S:C12H14N4O4
Molecular Weight
786.81 g/mol
Mechanism of Action
- Inhibition of dihydropteroate synthase
- Inhibition of dihydrofolate reductase
Indications
- Malaria prophylaxis
- Treatment of uncomplicated falciparum malaria
Common Dosage Forms
- Tablet
Typical Dosage
- Adults: 3 tablets once a week for prophylaxis, as prescribed for treatment
Pediatric Dosage
- Dosage based on weight and age, as prescribed by a healthcare provider
Geriatric Dosage
- Dosage adjustment may be needed based on renal function
Side Effects
- Nausea
- Vomiting
- Diarrhea
- Dizziness
- Hypersensitivity reactions
Contraindications
- Hypersensitivity to sulphonamides or pyrimethamine
- Severe renal or hepatic impairment
Pregnancy Category
- Category C - Potential benefits may warrant use of the drug in pregnant women despite potential risks
Lactation Safety
- Limited data available; caution advised
Drug Interactions
- Decreased effect with concomitant use of antacids or products containing magnesium, aluminum, or calcium
- Potential for increased risk of adverse effects with methotrexate
Overdose Symptoms
- Nausea
- Vomiting
- Diarrhea
- Blurred vision
- Seizures
Antidote for Overdose
- No specific antidote; symptomatic and supportive treatment
Storage Conditions
- Store at room temperature away from moisture and heat
Pharmacokinetics
- Absorption: Well absorbed orally
- Distribution: Distributed widely in body tissues
- Metabolism: Metabolized in the liver
- Excretion: Excreted primarily in the urine
Precautions
- Caution in patients with G6PD deficiency
- Monitor for signs of hemolytic anemia
Warnings
- Risk of severe skin reactions in patients with HIV/AIDS